/https%3A%2F%2Fwww.reuters.com%2Fresizer%2F0pHkDXPyDevFeQt8a0ZpCvoJjgw%3D%2F1200x628%2Fsmart%2Ffilters%3Aquality%2880%29%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FOC6EZKJILZKTPM6WHJS567HBCU.jpg)
The case for testing Pfizer's Paxlovid for treating long COVID
Reports of two patients who found relief from long COVID after taking Pfizer Inc's antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical ...